Cleared Traditional

K211597 - EPIQ Series Diagnostic Ultrasound System

K211597 is the FDA 510(k) clearance for EPIQ Series Diagnostic Ultrasound System by Philips Medical Systems. It is a Class 2 Radiology device (product code IYN) cleared through the Traditional 510(k) pathway after a 107-day FDA review.

K211597 · Philips Medical Systems · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2021
Decision
107d
Days
Class 2
Risk

K211597 is an FDA 510(k) clearance for the EPIQ Series Diagnostic Ultrasound System, Affiniti Series Diagnostic Ultrasou.... Classified as System, Imaging, Pulsed Doppler, Ultrasonic within the IYN classification (a category covering pulsed Doppler and ultrasound imaging systems), Class II - Special Controls.

Submitted by Philips Medical Systems (Bothell, US). The FDA issued a Cleared decision on September 8, 2021 after a review of 107 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1550 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Philips Medical Systems devices

Submission Details

510(k) Number K211597 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 24, 2021
Decision Date September 08, 2021
Days to Decision 107 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
At panel average
Panel avg: 107d · This submission: 107d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IYN System, Imaging, Pulsed Doppler, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYN System, Imaging, Pulsed Doppler, Ultrasonic

All 779
Devices cleared under the same product code (IYN) and FDA review panel - the closest regulatory comparables to K211597.
Versana Premier
K210438 · GE Medical Systems Ultrasound and Primary Care Diagnostics · Sep 2021
LOGIQ E10
K211488 · Ge Healthcare · Sep 2021
HERA W9, HERA W10 Diagnostic Ultrasound System
K211824 · Samsung Medison Co., Ltd. · Sep 2021
V8 Diagnostic Ultrasound System
K211945 · Samsung Medison Co., Ltd. · Sep 2021
LOGIQ E10s, LOGIQ Fortis
K211524 · Ge Healthcare · Aug 2021
Exo Iris
K211527 · Exo Imaging, Inc. · Aug 2021